v3.26.1
Stock Options and Restricted Stock - Summary of Activity for Stock Option Programs (Detail) - $ / shares
 3 Months Ended 12 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Dec. 31, 2025
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of options beginning balance 795,227 798,058 913,909
Granted 0 0 0
Cancelled (2,255) (607) (33,770)
Exercised (13,154) [1] (2,224) [1] (82,081)
Number of options ending balance 779,818 [2] 795,227 798,058
Options exercisable 779,818 [2]   798,058
Exercise price per share, lower range limit beginning balance $ 2.14 $ 2.14 $ 2.14
Exercise price per share, upper range limit beginning balance 7.25 7.25 9.38
Exercise price per share, granted 0 0 0
Exercise price per share, cancelled   0  
Exercise price per share, lower range limit ending balance 2.14 [2] 2.14 2.14
Exercise price per share, upper range limit ending balance 7.25 [2] 7.25 7.25
Exercise price per share, option exercisable lower range limit 2.14 [2]   2.14
Exercise price per share, option exercisable upper range limit 7.25 [2]   9.38
Weighted average exercise price, beginning balance 6.5 6.5 6.52
Weighted average exercise price, granted 0 0 0
Weighted average exercise price, cancelled 6.52 5.98 7.37
Weighted average exercise price, exercised 6.68 [1] 5.85 [1] 6.29
Weighted average exercise price, ending balance 6.5 [2] 6.5 6.5
Weighted average exercise price, options exercisable 6.5 [2]   6.5
Minimum [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Exercise price per share, cancelled 4.89   4.89
Exercise price per share, exercised 4.89 [1] 4.89 [1] 4.89
Maximum [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Exercise price per share, cancelled 7.25   9.38
Exercise price per share, exercised $ 7.25 [1] $ 7.25 [1] $ 7.25
[1] The aggregate intrinsic value, which represents the difference between the price of the Company’s common stock at the exercise date and the related exercise price of the underlying options, was less than $0.1 million for the three and six months ended June 30, 2026 and $0.3 million for the year ended December 31, 2025.
[2] The aggregate intrinsic value of outstanding options, which represents the difference between the price of the Company’s common stock at June 30, 2026 and the related exercise price of the underlying options, was $2.9 million for outstanding options, all of which had previously vested. The remaining contractual life was 3.7 years for outstanding options at June 30, 2026